Pharma Journalist - Page 851 of 923 -

Gilead Completes $7.8 Billion Arcellx Acquisition Deal

EU Approves Rhapsido for Chronic Hives Treatment

Lilly to Acquire Ajax in $2.3 Billion Deal

Labcyte and SEngine Precision Medicine Collaborate to Offer Functional Drug Screening for Oncology

FDA approval brings first gene therapy to the United States

Alimera Sciences Signs Agreement for Exclusive Distributor of ILUVIEN in France

Thermo Fisher Scientific Completes Acquisition Of Patheon

Gilead Sciences to Acquire Kite Pharma for $11.9 Billion

Daiichi Sankyo Enters Worldwide Licensing Agreement with Boston Pharmaceuticals

Kedrion Biopharma and Kamada Receive FDA Approval of KEDRAB

FDA Grants Priority Review for Genentech’s Gazyva in Previously Untreated Follicular Lymphoma

Otsuka & Mylan Announce License Agreement to Commercialize Delamanid (Deltyba™)

FDA Grants Priority Review to Genentech’s Emicizumab for Hemophilia A with Inhibitors